A Case Report of Myxedema Coma in the Setting of Normal Thyroid Stimulating Hormone
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Myxedema coma (MC) is a potentially fatal complication of hypothyroidism, with a high mortality rate. It is a clinically diagnosed condition, where the symptoms are related to decreased metabolic effects due to low active thyroid hormones. This case report highlights a severe case of MC, despite the thyroid stimulating hormone (TSH) being normal and the free thyroxine (FT4) being very mildly decreased.
References
1.
Dolkar T, Zouetr M, Shankar M, Rayapureddy A, Shiferaw-Deribe Z
. Subclinical Hypothyroidism Presenting as Myxedema Coma: Case Report and Literature Review. Cureus. 2022; 14(6):e25588.
PMC: 9249995.
DOI: 10.7759/cureus.25588.
View
2.
Bolk N, Visser T, Nijman J, Jongste I, Tijssen J, Berghout A
. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010; 170(22):1996-2003.
DOI: 10.1001/archinternmed.2010.436.
View
3.
Menendez M, Majekodunmi T, Chohan F, Perez-Castaneda A, Maldonado Rivera H, Angueira-Serrano E
. A Rare Case of Myxedema Coma Precipitated by a Single Dose of Haloperidol in a Patient With Paranoid Schizophrenia. Cureus. 2023; 15(9):e45190.
PMC: 10571067.
DOI: 10.7759/cureus.45190.
View
4.
Mallipedhi A, Vali H, Okosieme O
. Myxedema coma in a patient with subclinical hypothyroidism. Thyroid. 2010; 21(1):87-9.
DOI: 10.1089/thy.2010.0175.
View
5.
Skelin M, Lucijanic T, Amidzic Klaric D, Resic A, Bakula M, Liberati-cizmek A
. Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review. Clin Ther. 2017; 39(2):378-403.
DOI: 10.1016/j.clinthera.2017.01.005.
View